- Home
- CIEN vs LEGN Comparison
CIEN vs LEGN Comparison
Compare CIEN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIEN
- LEGN
- Stock Information
- Founded
- CIEN 1992
- LEGN 2014
- Country
- CIEN United States
- LEGN United States
- Employees
- CIEN N/A
- LEGN N/A
- Industry
- CIEN Telecommunications Equipment
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- CIEN Utilities
- LEGN Health Care
- Exchange
- CIEN Nasdaq
- LEGN Nasdaq
- Market Cap
- CIEN 8.4B
- LEGN 7.0B
- IPO Year
- CIEN 1997
- LEGN 2020
- Fundamental
- Price
- CIEN $79.92
- LEGN $28.33
- Analyst Decision
- CIEN Buy
- LEGN Strong Buy
- Analyst Count
- CIEN 13
- LEGN 13
- Target Price
- CIEN $78.62
- LEGN $75.67
- AVG Volume (30 Days)
- CIEN 1.4M
- LEGN 1.6M
- Earning Date
- CIEN 06-05-2025
- LEGN 05-13-2025
- Dividend Yield
- CIEN N/A
- LEGN N/A
- EPS Growth
- CIEN N/A
- LEGN N/A
- EPS
- CIEN 0.55
- LEGN N/A
- Revenue
- CIEN $4,049,506,000.00
- LEGN $728,303,000.00
- Revenue This Year
- CIEN $12.65
- LEGN $64.21
- Revenue Next Year
- CIEN $8.89
- LEGN $53.69
- P/E Ratio
- CIEN $146.30
- LEGN N/A
- Revenue Growth
- CIEN N/A
- LEGN 112.46
- 52 Week Low
- CIEN $44.69
- LEGN $27.34
- 52 Week High
- CIEN $101.44
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- CIEN 69.15
- LEGN 36.81
- Support Level
- CIEN $79.00
- LEGN $27.34
- Resistance Level
- CIEN $81.34
- LEGN $33.30
- Average True Range (ATR)
- CIEN 2.17
- LEGN 1.91
- MACD
- CIEN 0.54
- LEGN -0.30
- Stochastic Oscillator
- CIEN 80.16
- LEGN 13.51
About CIEN Ciena Corporation
Ciena Corp is a network and technology company. It provides network hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks. It serves various industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises world-wide. The business activities function through Networking Platforms which generates maximum revenue; Platform Software and Services; Blue Planet Automation Software, and Global Services segments. Geographically, the company derives a majority of its revenue from the Americas, and the rest from the Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA) region.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.